Articles by Disease (Colorectal Cancers)

Editorial [Hot Topic: Targeted Cancer Therapies: Current Status and Future Directions (Guest Editors: Ioannis Starakis)]

Journal: Current Medicinal Chemistry
Volume: 18
Page: 1573-1574
Author(s): Ioannis Starakis

The Endocannabinoid System in the Cancer Therapy: An Overview

Journal: Current Medicinal Chemistry
Volume: 18
Page: 1575-1583
Author(s): C. Grimaldi and A. Capasso

Pathophysiology and Pharmacological Targeting of Tumor-Induced Bone Disease: Current Status and Emerging Therapeutic Interventions

Journal: Current Medicinal Chemistry
Volume: 18
Page: 1584-1598
Author(s): V.T. Labropoulou, A.D. Theocharis, A. Symeonidis, S.S. Skandalis, N.K. Karamanos and H.P. Kalofonos

Targeted Therapy in Colorectal Cancer: Current Status and Future Challenges

Journal: Current Medicinal Chemistry
Volume: 18
Page: 1599-1612
Author(s): A.K. Koutras, I. Starakis, U. Kyriakopoulou, P. Katsaounis, A. Nikolakopoulos and H.P. Kalofonos

Mechanisms of Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Patients with Advanced Non-Small-Cell Lung Cancer: Clinical and Molecular Considerations

Journal: Current Medicinal Chemistry
Volume: 18
Page: 1613-1628
Author(s): A. Pallis, E. Briasoulis, H. Linardou, C. Papadimitriou, D. Bafaloukos, P. Kosmidis and S. Murray

Incorporation of Targeted Agents in the Management of Patients with Advanced Gastric Cancer

Journal: Current Medicinal Chemistry
Volume: 18
Page: 1629-1639
Author(s): G. Pentheroudakis and A. Stoyianni

Targeted Therapies and other Agents as First-Line Maintenance and Beyond: Particular Benefit in Pulmonary Adenocarcinoma Patients

Journal: Current Medicinal Chemistry
Volume: 18
Page: 1640-1650
Author(s): F. Petrelli, K. Borgonovo, M. Cabiddu, M. Ghilardi and S. Barni